2002, Number 5
<< Back Next >>
Gac Med Mex 2002; 138 (5)
Carcinoma renal de células cromófobas. Un estudio clínico patológico de 36 casos.
Alvarado-Cabrero I, Atencio-Chan A, Rodríguez C, Sosa-Romero A
Language: Spanish
References: 15
Page: 421-426
PDF size: 372.40 Kb.
ABSTRACT
Introduction: Chromophobe renal cell carcinoma (CCRC) comprises 5% of neoplasms of renal tubular epithelium. CCRC may have a slightly better prognosis than clear cell carcinoma, but outcome data are limited.
Objective: In this study. we analyzed 250 renal cell carcinomas to a) determine frequency of CCRC at our Hospital and b) analyze clinical and pathologic features of CCRCs.
Methods: A total of 250 renal carcinomas were analyzed between March 1990 and March 1999. Tumors were classified according to well-established histologic criteria to determine stage of disease; the system proposed by Robson was used
Results: Of 250 renal cell carcinomas analyzed, 36 were classified as chromophobe renal cell carcinoma, representing 14% of the group studied. The tumors had an average diameter of 14 cm. Robson staging was possible in all cases, and 10 patients were stage 1) 11 stage II; 10 stage III, and five stage IV. The average follow-up period was 4 years and 18 (53%) patients were alive without disease. Conclusion: The highly favorable pathologic stage (RI-RII, 58%) and the fact that the majority of patients were alive and disease-free suggested a more favorable prognosis for this type of renal cell carcinoma.
REFERENCES
Epidemiología. En: Registro Histopatológico de Neoplasias en México. Secretaría de Salud, México. 1999-2000.
Bannash P, Schacht U, Storch E. Morphogenese und mikromorphologie epitheliarler. Induktion und Histologie der Tumoren 1974;81:311-331.
Thoenes W, Storkel S, Rumpelt HJ. Human chromophobe renal cell carcinoma. Virchows Arch 1985;48:207-217.
Kovacks A, Kovacks G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer 1992;4:267-268.
Presti JC Jr, Rao PH, Chen Q, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991;51;1544-1552.
Fuhrman S, Lasky J, Limas C. Prognostic’s significance of morphologic renal parameters in cell carcinoma. Am J Surg Pathol 1982;6:655-663.
Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol 1963;89:3742.
Medeiros LJ, Weiss LM. Renal adenocarcinoma. In: Eble JN, Ed. Tumors and tumor-like conditions of the kidneys and ureters. Churchill Livingstone. New York, 1990.
Alvarado-Cabrero I, Atencio A, Rodriguez C. Carcinoma de células cromófobas. Un estudio clínico-patológico de 34 casos. Patología 2001;39:53.
Crotty TB, Farrow GM, Lieber MM. Chromophobe renal cell carcinoma: Clinicopathological features of 50 cases. J Urol 1995;154:964-967.
Akhtar M, Tulbah A, Kardar A, et al. Sarcomatoid renal ceIl carcinoma: The chromophobe connection. Am J Surg Pathol 1997;21:1188-1195.
Thoene W, Storkel S, Rumpelt HJ, et al. Chromophobe cell renal carcinoma and its variants. A report on 32 cases. J Pathol 1988;155:277-287.
Bonsib SM. Renal chromophobe cell carcinoma: The relationship between cytoplasmic vesicles and colloidal iron stain. J Urol Pathol 2000;18:560-564.
Amin MB, Moch U, Alvarado-Cabrero I, Jimenez RE, et al. Chromophobe renal cell carcinoma: Histopathologic and prognostic features in 116 cases. Mod Pathol 2001;14:S578.
Alvarado-Cabrero I, Atencio-Chan A, Gayborg J, Rodriguez C. Factores pronósticos asociados a la sobrevida de pacientes con carcinoma de células renales. En preparación para publicación.